Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Revue De Pneumologie Clinique|July 1, 2008
[Anemia and lung cancer]J-M Bréchot, J-F Morère
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 26, 2020
[Prostate cancer screening in France: Results from the EDIFICE surveys]J-F Morère, C Touboul, C Lhomel, et al.
American Journal of Clinical Oncology|February 1, 1988
Treatment of advanced epithelial ovarian cancer with a cis-dichloro-diammine platinum, cyclophosphamide, and bleomycin combinationL Israël, J L Breau, J F Morère, et al.
Pathologie-Biologie|October 1, 1991
[The blood-brain barrier: implications for chemotherapy in brain tumors]C Boaziz, J L Breau, J F Morère, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 8, 1981
[Granulomas of the liver : a clinical and pathological study of fifty-five cases (author's transl)]D Meyniel, R Piéron, M Favre, et al.
Presse Medicale (Paris, France : 1983)|June 21, 1986
[Induction of objective responses by an anticancer chemotherapy based on the prolonged combination of bleomycin and cisplatin. 1062 cases]L Israel, J L Breau, J F Morère, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 15, 1998
Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BBR Bagheri-Yarmand, Y Kourbali, J F Morère, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): interference with the FGF2 autocrine loop [corrected]R Bagheri-Yarmand, J F Liu, D Ledoux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Carboxymethyl benzylamide dextran and tamoxifen combination inhibits tumor growth and angiogenesisR Bagheri-Yarmand, Y Hamma-Kourbali, P Bissieres, et al.
Annales D'Urologie|January 1, 1991
[Interferon and interleukin 2 in metastatic cancer of the kidney. Apropos of 18 cases]C Boaziz, J L Breau, J F Morère, et al.
Pageof 3